LIPO ESCULTURA capsules, 250 mg, 60-count bottles, Distributed By: JAT Productos Naturales Corp.,...

FDA Recall #D-0860-2016 — Class I — December 3, 2015

Recall #D-0860-2016 Date: December 3, 2015 Classification: Class I Status: Terminated

Product Description

LIPO ESCULTURA capsules, 250 mg, 60-count bottles, Distributed By: JAT Productos Naturales Corp., BROOKLYN, NY 11238, www.lipoesculturatreatment.com

Reason for Recall

Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.

Recalling Firm

Lipo Escultura Corp. — Brooklyn, NY

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

unknown

Distribution

Nationwide via Internet sales

Code Information

All lots

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated